Search Results

Overactive bladder medication — do we need to revisit trospium chloride for our elderly patients?

• Authors : Bhide, Alka A.¹ (AUTHOR); Digesu, G. A.¹ (AUTHOR) ; Swift, Steven² (AUTHOR)

Subjects: *OVERACTIVE bladder; *OLDER patients; *DRUGS

• Source: International Urogynecology Journal. May2023, Vol. 34 Issue 5, p961-962. 2p.

Record details

Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms.

• Authors : Jeong, Seong; Homma, Yukio; Oh, Seung-June

Subjects: OVERACTIVE bladder; KOREANS; PSYCHOMETRICS

• Source: Quality of Life Research. Feb2014, Vol. 23 Issue 1, p285-292. 8p. 1 Diagram, 4 Charts, 1 Graph.

Record details

Oxybutynin-associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment.

• Authors : Chancellor, Michael B.¹ (AUTHOR) ; Lucioni, Alvaro² (AUTHOR); Staskin, David³ (AUTHOR)

Subjects: *OVERACTIVE bladder; *COGNITION disorders; *MUSCARINIC receptors

• Source: Urology. Apr2024, Vol. 186, p123-129. 7p.

Record details

Kyorin, Sumitomo to introduce drug for overactive bladder in Taiwan & other Asian countries.

Subjects: *LICENSE agreements; OVERACTIVE bladder; PARASYMPATHOLYTIC agentsTAIWAN

• Source: BioSpectrum. Apr2023, Vol. 21 Issue 4, p13-13. 1/3p.

Record details

Editorial Comment from Dr Sekido to Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double-blind, placebo-controlled trial.

• Authors : Sekido, Noritoshi¹

Subjects: *OVERACTIVE bladder; *PLACEBOS; *ALTERNATIVE medicineJAPAN

• Source: International Journal of Urology. May2011, Vol. 18 Issue 5, p373-374. 2p.

Record details

An eco-friendly one-pot spectrofluorimetric approach for the facile determination of overactive bladder drug, tolterodine: Application to dosage forms and biological fluids.

• Authors : Derayea, Sayed M.¹ (AUTHOR) ; Badr El-Din, Khalid M.¹ (AUTHOR); Ahmed, Ahmed S.² (AUTHOR)

Subjects: *OVERACTIVE bladder; *PARASYMPATHOLYTIC agents; *TOLTERODINEUNITED States. Food & Drug Administration

• Source: Spectrochimica Acta Part A: Molecular & Biomolecular Spectroscopy. Apr2024, Vol. 311, pN.PAG-N.PAG. 1p.

Record details

Efficacy of sacral transcutaneous electrical nerve stimulation in patients with overactive bladder refractory to anticholinergic treatment: a prospective multi-center study.

• Authors : Coronas Soucheiron, M.¹ ; Casal Beloy, I.^2,3; Villalón Ferrero, F. N.⁴

Subjects: *TRANSCUTANEOUS electrical nerve stimulation; *OVERACTIVE bladder; *BLADDER diseases

• Source: Cirugía Pediátrica (English Edition). Oct2023, Vol. 36 Issue 4, p180-185. 6p.

Record details

What Is the Current Role of β3-Adrenergic Receptor Agonists and How Do They Work?

• Authors : Chapple, Christopher R.¹

Subjects: *OVERACTIVE bladder; *PARASYMPATHOLYTIC agents; *ADRENERGIC beta agonists

• Source: European Urology. Feb2019, Vol. 75 Issue 2, p283-284. 2p.

Record details

Characteristics of providers who only prescribed anticholinergic medications for overactive bladder in 2019.

• Authors : Carr, D.N. (AUTHOR); Macharia, A. (AUTHOR); Hacker, M.R. (AUTHOR)

Subjects: OVERACTIVE bladder; PARASYMPATHOLYTIC agents

• Source: American Journal of Obstetrics & Gynecology. 2023 Supplement, Vol. 228 Issue 3, pS886-S887. 2p.

Record details

Characteristics of providers who prescribed only anticholinergic medications for overactive bladder in 2020.

• Authors : Carr, Danielle N. (AUTHOR); Macharia, Annliz (AUTHOR); Hacker, Michele R. (AUTHOR)

Subjects: OVERACTIVE bladder; MEDICAID; MEDICAID beneficiaries

• Source: American Journal of Obstetrics & Gynecology. Sep2023, Vol. 229 Issue 3, p316.e1-316.e7. 1p.

Record details